NANTKWEST
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 13 May 2025)
What this means for you
Registered since 26 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87218766
- Registration number
- 5366088
- Mark type
- Stylized text
- Filed
- 28 Oct 2016
- Published for opposition
- 21 Mar 2017
- Registered
- 26 Dec 2017
- Attorney of record
- Alicia M. Passerin
Goods and services
- Class 001 — Chemicals: Cells and cell-derived preparations for scientific, laboratory, medical, clinical, and therapeutic research
- Class 005 — Pharmaceuticals: Cell-derived preparations for clinical, medicinal, and therapeutic purposes
- Class 042 — Scientific and technological services: [ Research in the fields of cancer and infectious and inflammatory diseases; product development in the fields of science, medicine, pharmaceuticals, therapeutics and research related thereto ]
- Class 044 — Medical, beauty and agricultural services: [ Providing information relating to clinical, medicinal, and therapeutic properties of cells and cell-derived preparations ]
Owner
- IMMUNITYBIO, INC., SAN DIEGO, CA, US
- NantKwest, Inc., Culver City, CA, US
- NantKwest, Inc., Culver City, CA, US
- NantKwest, Inc., Culver City, CA, US
Prosecution history
- 13 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 May 2025 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 May 2025 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 22 Nov 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 22 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
- 26 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 22 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Nov 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Oct 2017 — USE AMENDMENT FILED
- 14 Nov 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Oct 2017 — TEAS STATEMENT OF USE RECEIVED